This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jordan, R. C. Articles by Slingerland, J. Search for Related Content PubMed PubMed Citation Articles by Jordan, R. C. Articles by Slingerland, J.

American Journal of Pathology, Vol 152, 585-590, Copyright © 1998 by American Society for Investigative Pathology

REGULAR ARTICLES

Reduced levels of the cell-cycle inhibitor p27Kip1 in epithelial dysplasia and carcinoma of the oral cavity

RC Jordan, G Bradley and J Slingerland
Department of Oral Pathology, Faculty of Dentistry, University of Toronto, Ontario, Canada. richard.jordan@sunnybrook.on.ca

Recent studies have shown that the cyclin-dependent kinase (cdk) inhibitors play important roles in cell cycle progression in normal cells. Alterations in the cdk inhibitors also appear to be important in cancer development in a number of human tumors. p27Kip1 is a member of the CIP/KIP family of cdk inhibitors that negatively regulates cyclin- cdk complexes. Reduced levels of p27Kip1 protein have been identified in a number of human cancers, and in some cases reduced p27Kip1 is associated with an increase in proliferative fraction. In the present study, we examined p27Kip1 protein by immunohistochemistry in 10 normal and 36 dysplastic epithelia and in 8 squamous cell carcinomas from one anatomical site within the oral cavity, the floor of the mouth. Proliferative activity was assessed in serial sections by determining the expression of the cell cycle proteins Ki-67 and cyclin A. p27kip1 protein was significantly reduced in oral dysplasias and carcinomas compared with that in normal epithelial controls. In addition, there was a significant reduction in p27Kip1 protein between low- and high- grade dysplasias, suggesting that changes in p27Kip1 expression may be an early event in oral carcinogenesis. There was increasing expression of Ki-67 and cyclin A proteins with increasingly severe grades of dysplasia compared with normal controls. Although there was a strong correlation between Ki-67 and cyclin A scores (r2= 0.61) for all categories of disease, there was a weak negative correlation between Ki- 67 and p27Kip1 levels (r2 = 0.29) and between cyclin A and p27Kip1 levels (r2 = 0.25). In conclusion, this study has found that a reduction in the proportion of cells expressing p27Kip1 protein is frequently associated with oral dysplasia and carcinoma from the floor of the mouth. Furthermore, reductions in p27Kip1 levels are associated with increased cell proliferation, although other changes likely contribute to altered cell kinetics during carcinogenesis at this site.

This article has been cited by other articles:

				K. E. A. LaRue, M. Khalil, and J. P. Freyer Microenvironmental Regulation of Proliferation in Multicellular Spheroids Is Mediated through Differential Expression of Cyclin-Dependent Kinase Inhibitors Cancer Res., March 1, 2004; 64(5): 1621 - 1631. [Abstract] [Full Text] [PDF]

				M. A. Ghanem, T. H. Van der Kwast, M. K. Sudaryo, R. B. Mathoera, M. M. van den Heuvel, A.-A. M. Al-Doray, R. M. Nijman, and G. J. van Steenbrugge MIB-1 (KI-67) Proliferation Index and Cyclin-Dependent Kinase Inhibitor p27Kip1 Protein Expression in Nephroblastoma Clin. Cancer Res., January 15, 2004; 10(2): 591 - 597. [Abstract] [Full Text] [PDF]

				A A Khan, P D Abel, K S Chaudhary, Z Gulzar, G W H Stamp, and E-N Lalani Inverse correlation between high level expression of cyclin E and proliferation index in transitional cell carcinoma of the bladder Mol. Pathol., December 1, 2003; 56(6): 353 - 361. [Abstract] [Full Text] [PDF]

				L. Lo Muzio, G. Pannone, R. Leonardi, S. Staibano, M.D. Mignogna, G. De Rosa, Y. Kudo, T. Takata, and D.C. Altieri Survivin, a Potential Early Predictor of Tumor Progression in the Oral Mucosa J. Dent. Res., November 1, 2003; 82(11): 923 - 928. [Abstract] [Full Text] [PDF]

				H. Nakabayashi, I. Sunada, and M. Hara Immunohistochemical Analyses of Cell Cycle-related Proteins, Apoptosis, and Proliferation in Pituitary Adenomas J. Histochem. Cytochem., September 1, 2001; 49(9): 1193 - 1194. [Abstract] [Full Text] [PDF]

				M. Gstaiger, R. Jordan, M. Lim, C. Catzavelos, J. Mestan, J. Slingerland, and W. Krek Skp2 is oncogenic and overexpressed in human cancers PNAS, April 12, 2001; (2001) 81474898. [Abstract] [Full Text]

				K. Ravanko, K. Järvinen, A. Paasinen-Sohns, and E. Hölttä Loss of p27Kip1 from Cyclin E/Cyclin-dependent Kinase (CDK) 2 but not from Cyclin D1/CDK4 Complexes in Cells Transformed by Polyamine Biosynthetic Enzymes Cancer Res., September 1, 2000; 60(18): 5244 - 5253. [Abstract] [Full Text]

				A. M. Oliveira, A. G. Nascimento, S. H. Okuno, and R. V. Lloyd p27kip1 Protein Expression Correlates With Survival in Myxoid and Round-Cell Liposarcoma J. Clin. Oncol., August 15, 2000; 18(15): 2888 - 2893. [Abstract] [Full Text] [PDF]

				A. M. Mirza, A. D. Kohn, R. A. Roth, and M. McMahon Oncogenic Transformation of Cells by a Conditionally Active Form of the Protein Kinase Akt/PKB Cell Growth Differ., June 1, 2000; 11(6): 279 - 292. [Abstract] [Full Text]

				G. Pruneri, L. Pignataro, N. Carboni, R. Buffa, D. Di Finizio, B. M. Cesana, and A. Neri Clinical Relevance of Expression of the CIP/KIP Cell-Cycle Inhibitors p21 and p27 in Laryngeal Cancer J. Clin. Oncol., October 1, 1999; 17(10): 3150 - 3159. [Abstract] [Full Text] [PDF]

				C. C. R. Lee, T. Ichihara, S. Yamamoto, H. Wanibuchi, K. Sugimura, S. Wada, T. Kishimoto, and S. Fukushima Reduced expression of the CDK inhibitor p27KIP1 in rat two-stage bladder carcinogenesis and its association with expression profiles of p21WAF1/Cip1 and p53 Carcinogenesis, September 1, 1999; 20(9): 1697 - 1708. [Abstract] [Full Text] [PDF]

				R. V. Lloyd, L. A. Erickson, L. Jin, E. Kulig, X. Qian, J. C. Cheville, and B. W. Scheithauer p27kip1: A Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human Cancers Am. J. Pathol., February 1, 1999; 154(2): 313 - 323. [Abstract] [Full Text] [PDF]

				B. E. Clurman and P. Porter New insights into the tumor suppression function of P27Kip1 PNAS, December 22, 1998; 95(26): 15158 - 15160. [Full Text] [PDF]

				H. Kawana, J.-i. Tamaru, T. Tanaka, A. Hirai, Y. Saito, M. Kitagawa, A. Mikata, K. Harigaya, and T. Kuriyama Role of p27Kip1 and Cyclin-Dependent Kinase 2 in the Proliferation of Non-Small Cell Lung Cancer Am. J. Pathol., August 1, 1998; 153(2): 505 - 513. [Abstract] [Full Text] [PDF]

				V. A. Florenes, G. M. Mælandsmo, R. S. Kerbel, J. M. Slingerland, J. M. Nesland, and R. Holm Protein Expression of the Cell-Cycle Inhibitor p27Kip1 in Malignant Melanoma : Inverse Correlation with Disease-Free Survival Am. J. Pathol., July 1, 1998; 153(1): 305 - 312. [Abstract] [Full Text] [PDF]

				M. Gstaiger, R. Jordan, M. Lim, C. Catzavelos, J. Mestan, J. Slingerland, and W. Krek Skp2 is oncogenic and overexpressed in human cancers PNAS, April 24, 2001; 98(9): 5043 - 5048. [Abstract] [Full Text] [PDF]